Skip to content

Three-dimensional volumetric assessment and stability of simultaneously placed implant following sinus floor augmentation with deproteinized human demineralized tooth matrix or deproteinized bovine bone mineral: a randomized controlled clinical trial

Three-dimensional volumetric assessment and stability of simultaneously placed implant following sinus floor augmentation with deproteinized human demineralized tooth matrix or deproteinized bovine bone mineral: a randomized controlled clinical trial

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
TCTR
Registry ID
TCTR20200929002
Enrollment
26
Registered
2020-09-29
Start date
2020-10-05
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy patients need simultaneous implant placement with sinus augmentation utilizing the lateral window technique and had residual alveolar bone heights between 3 to 6 mm. Demineralized deproteinized tooth matrix Graft sinus floor reduction Implant stability Sinus floor augmentation Tooth graft Volume reduction

Interventions

A full thickness mucoperiosteal incision, the lateral sinus wall was exposed and the Schneiderian membrane was elevated through a lateral bone window that was created using a round bur under sterile s
H Implantmed device using resonance frequency analysis. The window was covered with a resorbable collagen membrane (Bio-Gide) and fixed with Ti-tack before closing the flap, which was secured with Vic
Experimental Procedure/Surgery,Experimental Procedure/Surgery
sinus augmented will be augmented with dpDTM,sinus augmented will be augmented with DBBM

Sponsors

Ministry of Higher Education, Science, Research and Innovation, Prince of Songkla University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Healthy patients, the ages of 20-60 years 2. Required simultaneous implant placement with sinus augmentation (lateral window technique) 3. residual alveolar bone heights between 3 to 6 mm.

Exclusion criteria

Exclusion criteria: 1. Pregnancy or lactating 2. History of malignancy/radiotherapy/chemotherapy for malignancy in the past 5yrs. 3. Medical history is a contraindication for oral surgery treatment 4. Autoimmune disease/ Metabolic bone disease. 5. A patient just was diagnosed be malignancy and then need to treat urgency 6. Present active infection at maxillary sinus or chronic sinusitis after surgery 7. Long-term used of NSAIDs, steroid or antibiotic drugs 8. Bisphosphonate therapy 9. Untreated severe periodontal disease 10. The patient cannot follow appointment 11. heavy smokers (more than 10 cigarettes per day).

Design outcomes

Primary

MeasureTime frame
volume stability immediate, 6 months postoperative CBCT scan,graft height alteration immediate, 6 months postoperative CBCT scan

Secondary

MeasureTime frame
implant stability immediated and 6 months postoperation Resonance Frequency Analysis (RFA)

Countries

Thailand

Contacts

Public ContactSrisurang Suttapreyasri

Prince of Songkhla university

srisurang.s@psu.ac.th0879790055

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026